Insperity (NSP): Evaluating Valuation as HRScale Launch with Workday Sparks Growth Expectations
Insperity (NSP) is drawing investor attention following news of its soon-to-launch HRScale platform, developed in partnership with Workday. The initiative is aimed at expanding into the mid-market, which is expected to support the company’s revenue and profitability.
See our latest analysis for Insperity.
Even as Insperity gears up for its HRScale rollout, the company’s share price return has been on a downward trend, falling 10.24% over the past month and 35.81% year-to-date. In the longer term, total shareholder return stands at -41.15% over the past year. This reflects some uncertainty but also hints that fresh growth initiatives are arriving at a critical time.
If you’re watching how HR and business services evolve, now’s the perfect chance to broaden your perspective and discover fast growing stocks with high insider ownership
With the stock trading well below analyst targets despite new growth efforts, investors may be wondering whether an opportunity is being overlooked at these levels, or if the market has already factored in Insperity’s future upside.
Most Popular Narrative: 16.1% Undervalued
Insperity’s most-followed narrative suggests the stock has meaningful upside, implying a fair value 16.1% above the last close of $48.47. The narrative points to new business initiatives as potential inflection points for future valuation.
Launching HRScale with Workday and expanding AI-driven HR offerings positions Insperity for higher revenue growth and scalable margin improvements in the mid-market segment. Rising HR compliance complexity and increased SMB formation boost ongoing demand for bundled services, supporting long-term client growth and sustainable recurring revenue.
Curious how analysts justify such a bold valuation for a company mired in short-term losses? There is a key formula: future earnings, bigger margins, and a profit multiple that is rarely seen in slow-growth sectors. Want to know which projections drive this narrative higher? You’ll have to see the full story for the underlying assumptions.
Result: Fair Value of $57.75 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent healthcare cost inflation and execution risks related to the Workday rollout could challenge Insperity’s path to improved growth and margins.
Find out about the key risks to this Insperity narrative.
Another View: Earnings Multiple Sends a Warning
Looking at Insperity through the lens of its price-to-earnings ratio paints a very different picture. The company trades at 45.7 times earnings, more than double the average for both peers (21.9x) and its wider industry (26.7x), and well above its fair ratio of 34.8x. This wide gap suggests the market may be pricing in expectations that are difficult to meet. Could this add risk rather than opportunity at current levels?
See what the numbers say about this price — find out in our valuation breakdown.
Build Your Own Insperity Narrative
If you see the story differently or want to dig deeper into the numbers, you can quickly create your own perspective in just a few minutes. Do it your way
A great starting point for your Insperity research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Looking for More Investment Ideas?
Why settle for just one opportunity? Using the Simply Wall Street Screener, you can unlock a world of fresh investment potential before anyone else does.
- Maximize your income strategy and tap into these 19 dividend stocks with yields > 3% offering yields above 3% for reliable, steady returns.
- Ride the wave of rapid innovation and accelerate your portfolio with these 25 AI penny stocks, which are at the forefront of artificial intelligence breakthroughs.
- Spot tomorrow’s bargains early by targeting these 898 undervalued stocks based on cash flows, which are primed for long-term growth based on cash flow fundamentals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Insperity might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com